What is Humedix Co., Ltd.'s (200670.KQ) StockRank?

MoatMap's StockRank for Humedix Co., Ltd. (200670.KQ) is 55/100, with a Hold signal. This is a composite score combining Quality (63), Value (71), and Momentum (10) factor ranks across MoatMap's 20,000+ stock universe.

Does Humedix Co., Ltd. have an economic moat?

Humedix Co., Ltd. (200670.KQ) has a Quality factor score of 63/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Humedix Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Humedix Co., Ltd. (200670.KQ) is Hold, based on a StockRank of 55/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Humedix Co., Ltd. in?

Humedix Co., Ltd. (200670.KQ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

200670.KQ

HOLD

Humedix Co., Ltd. · Healthcare · South Korea · $191M · Avg Vol: $770K/d

StockRank

P/E (TTM)

5.4x

ROE

7.3%

D/E

0.2x

Dividend %

4.1%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

COMPANY DESCRIPTION

Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetics, and health functional food products.

FINANCIAL SUMMARY (USD)

Year	2021	2022	2023	2024	2025	CAGR
Revenue	—	80.2M	99.2M	105.4M	110.7M	11.3%
EPS	—	1.48	1.64	2.47	3.27	30.2%
Shares	—	10.0M	11.2M	11.2M	10.3M	+2.9%
Debt	19.3M	23.2M	1.8M	1.9M	0.9M	-53.7%
Equity	—	90.6M	129.0M	148.8M	195.1M	29.1%
Op CF	—	24.8M	20.1M	33.0M	29.4M	5.8%
Inv CF	—	35.1M	-10.1M	-8.2M	-65.4M	—
Fin CF	—	-6.9M	-16.8M	-6.4M	-9.8M	—

PRICE (1Y)-24.4%

SMA 50SMA 200

$16.51

RSI (14)

53.6

52W High

$48.89

From 52W High

0.3%

SCORE BREAKDOWN

Quality

ROIC

21.1%92.1

ROE

7.3%63.5

GP/Assets

13.5%32.4

Op. Margin

15.4%75.7

FCF/Assets

2.4%59.2

Piotroski

782.3

Int. Cover

50.0x88.5

D/E Ratio

0.23x49.9

Current Ratio

3.06x54.3

Value

P/E (TTM)

5.4x96.9

EV/EBITDA

8.9x72.7

P/FCF

38.0x29.9

P/B

0.9x85.9

P/S

2.7x59.2

Div Yield

4.1%84.7

Momentum

52W High %

34%10.5

RS 6M

-145%3.8

SMA 50/200

0.75x8.5

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

-88%2.5

FUNDAMENTALS

Market Cap

$191M

P/E (Forward)

6.6x

Gross Margin

39.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 200670.KQ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
200670.KQ	Humedix Co., Ltd.(you)	$191M	55	HOLD
206650.KQ	EuBiologics Co., Ltd.	$214M	59	HOLD
271980.KS	Jeil Pharmaceutical Co.,Ltd	$98M	55	HOLD
293480.KS	Hana Pharm Co., Ltd.	$103M	61	HOLD
476060.KQ	Onconic Therapeutics	$454M	57	HOLD
176750.KQ	DuChemBIO Co.,Ltd.	$110M	46	HOLD
003120.KS	Ilsung Is Co., Ltd.	$91M	47	HOLD
003000.KS	Bukwang Pharmaceutical Co., Ltd.	$272M	39	HOLD
106190.KQ	High Tech Pharm Co., Ltd.	$100M	66	BUY
102460.KS	REYON Pharmaceutical Co., Ltd.	$118M	38	HOLD

Peer medians: ROE 0.1% · P/E 16.8x · Gross margin 43.8%

Humedix Co., Ltd. (200670.KQ) — Stock Score Summary

Humedix Co., Ltd. (200670.KQ) has a MoatMap StockRank of 55/100 based on Quality (63/100), Value (71/100), and Momentum (10/100) factor scores. The current signal is HOLD.

Key Financial Metrics

Price	$16.51
Market Cap	$191M
P/E (TTM)	5.35
P/E (Forward)	6.56
Price/Book	0.92
Return on Equity	7.3%
Return on Invested Capital	21.1%
Debt/Equity	23.06
Gross Margin	39.7%
Operating Margin	15.4%
Revenue Growth	-13.1%
Dividend Yield	4.1%
Free Cash Flow	$5M

Humedix Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Humedix Co., Ltd.’s (200670.KQ) StockRank?: MoatMap’s StockRank for Humedix Co., Ltd. (200670.KQ) is 55/100, with a Hold signal. It is a composite of Quality (63), Value (71), and Momentum (10) factor ranks across MoatMap’s 20,000+ stock universe.
Does Humedix Co., Ltd. have an economic moat?: Humedix Co., Ltd. (200670.KQ) has a Quality factor score of 63/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Humedix Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Humedix Co., Ltd. (200670.KQ) is Hold, based on a StockRank of 55/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Humedix Co., Ltd. in?: Humedix Co., Ltd. (200670.KQ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).